Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Reimbursement
Pharma
Bluebird pushes Lyfgenia's US coverage to nearly 200M people
A second outcomes-based reimbursement agreement has pushed up Lyfgenia’s coverage range to nearly 200 million people in the U.S.
Angus Liu
Jan 4, 2024 11:15am
Bluebird signs first coverage deal for SCD gene therapy Lyfgenia
Dec 14, 2023 11:04am
Is the cost of Vertex's Trikafta hampering CF treatment?
Feb 14, 2022 11:46am
Medicare received majority of comments iffy on Biogen's Aduhelm
Feb 1, 2022 11:34am
Biogen wants Aduhelm supporters to make their voices heard
Jan 13, 2022 11:13am
CMS draft 'could effectively spell the end' for Aduhelm: analyst
Jan 12, 2022 8:30am